المؤلفون: N. V. Toroptsova, E. L. Nasonov, Н. В. Торопцова, Е. Л. Насонов

المصدر: Rheumatology Science and Practice; Vol 62, No 2 (2024); 145-153 ; Научно-практическая ревматология; Vol 62, No 2 (2024); 145-153 ; 1995-4492 ; 1995-4484

مصطلحات موضوعية: клинические рекомендации, glucocorticoid-induced osteoporosis, fracture risk, osteoporosis treatment, guideline, глюкокортикоидный остеопороз, риск переломов, лечение остеопороза

وصف الملف: application/pdf

العلاقة: https://rsp.mediar-press.net/rsp/article/view/3543/2360Test; Michaud K, Wolfe F. Comorbidities in rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007;21(5):885-906. doi:10.1016/j.berh.2007.06.002; Баранова ИА, Ершова ОБ, Анаев ЭХ, Анохина ТН, Аношенкова ОН, Батын СЗ, и др. Оценка частоты и факторов риска низкоэнергетических переломов скелета по данным опроса больных хроническими воспалительными заболеваниями. Результаты многоцентрового исследования российской ассоциации по остеопорозу ГЛЮКОСТ. Остеопороз и остеопатии. 2014;17(3):9-14. doi:10.14341/osteo201439-14; Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Oral corticosteroids and fracture risk: Relationship to daily and cumulative doses. Rheumatology (Oxford). 2000;39(12):1383- 1389. doi:10.1093/rheumatology/39.12.1383; De Vries F, Bracke M, Leufkens HG, Lammers JW, Cooper C, Van Staa TP. Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum. 2007;56(1):208-214. doi:10.1002/art.22294; Kanis JA, Johansson H, Oden A, McCloskey EV. Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporosis Int. 2011; 22:809-816. doi:10.1007/s00198-010-1524-7; Humphrey MB, Russell L, Danila MI, Fink HA, Guyatt G, Cannon M, et al. 2022 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken). 2023;75(12):2405-2419. doi:10.1002/acr.25240; Andrews JC, Schünemann HJ, Oxman AD, Pottie K, Meerpohl JJ, Coello PA, et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation’s direction and strength. J Clin Epidemiol. 2013;66(7):726-735. doi:10.1016/j.jclinepi.2013.02.003; Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al.; GRADE Working Group. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926. doi:10.1136/bmj.39489.470347.AD; Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53-58. doi:10.1210/jc.2010-2704; Allen CS, Yeung JH, Vandermeer B, Homik J. Bisphosphonates for steroid-induced osteoporosis [review]. Cochrane Database Syst Rev. 2016;10:CD001347. doi:10.1002/14651858.CD001347.pub2; Saag KG, Shane E, Boonen S, Marín F, Donley DW, Taylor KA, et al. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med. 2007;357(20):2028-2039. doi:10.1056/NEJMoa071408; Chandran M. The why and how of sequential and combination therapy in osteoporosis. A review of the current evidence. Arch Endocrinol Metab. 2022;66(5):724-738. doi:10.20945/2359-3997000000564; Reid DM, Devogelaer JP, Saag K, Roux C, Lau CS, Reginster JY, et al.; HORIZON investigators. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): A multicentre, double-blind, double-dummy, randomised controlled trial. Lancet. 2009;373(9671):1253- 1263. doi:10.1016/S0140-6736(09)60250-6; Saag KG, Wagman RB, Geusens P, Adachi JD, Messina OD, Emkey R, et al. Denosumab versus risedronate in glucocorticoidinduced osteoporosis: A multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study. Lancet Diabetes Endocrinol. 2018;6(6):445-454. doi:10.1016/S2213-8587(18)30075-5; Saag KG, Zanchetta JR, Devogelaer JP, Adler RA, Eastell R, See K, et al. Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial. Arthritis Rheum. 2009;60(11):3346-3355. doi:10.1002/art.24879; Patlas N, Golomb G, Yaffe P, Pinto T, Breuer E, Ornoy A. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology. 1999;60(2):68-73. doi:10.1002/(SICI)1096-9926(199908)60:23.0.CO;2-H; Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al.; Kidney Disease: Improving Global Outcomes (KDIGO). Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006;69(11):1945-1953. doi:10.1038/sj.ki.5000414; Hiramatsu R, Ubara Y, Sawa N, Sakai A. Hypocalcemia and bone mineral changes in hemodialysis patients with low bone mass treated with denosumab: A 2-year observational study. Nephrol Dial Transplant. 2021;36:1900-1907. doi:10.1093/ndt/gfaa359; Boonen S, Marin F, Obermayer-Pietsch B, Simões ME, Barker C, Glass EV, et al.; EUROFORS Investigators. Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis. J Clin Endocrinol Metab. 2008;93(3):852-860. doi:10.1210/jc.2007-0711; Cosman F, Keaveny TM, Kopperdahl D, Wermers RA, Wan X, Krohn KD, et al. Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene. J Bone Miner Res. 2013;28(6):1328-1336. doi:10.1002/jbmr.1853; Ettinger B, San Martin J, Crans G, Pavo I. Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate. J Bone Miner Res. 2004;19:745-751. doi:10.1359/JBMR.040117; Leder BZ, Tsai JN, Uihlein AV, Wallace PM, Lee H, Neer RM, et al. Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): Extension of a randomised controlled trial. Lancet. 2015;386(9999):1147-1155. doi:10.1016/S0140-6736(15)61120-5; Cosman F. Anabolic and antiresorptive therapy for osteoporosis: Combination and sequential approaches. Curr Osteoporos Rep. 2014;12:385-395. doi:10.1007/s11914-014-0237-9; Cosman F, Huang S, McDermott M, Cummings SR. Multiple vertebral fractures after denosumab discontinuation: FREEDOM and FREEDOM extension trials additional post hoc analyses. J Bone Miner Res. 2022;37(11):2112-2120. doi:10.1002/jbmr.4705; Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Pharmacological management of osteoporosis in postmenopausal women: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2019;104(5):1595-1622. doi:10.1210/jc.2019-00221; Kendler D, Chines A, Clark P, Ebeling PR, McClung M, Rhee Y, et al. Bone mineral density after transitioning from denosumab to alendronate. J Clin Endocrinol Metab. 2020;105(3):e255-e264. doi:10.1210/clinem/dgz095; Tutaworn T, Nieves JW, Wang Z, Levin JE, Yoo JE, Lane JM. Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: A retrospective study. Osteoporos Int. 2023;34(3):573-584. doi:10.1007/s00198-022-06648-9; Leder BZ, Tsai JN, Jiang LA, Lee H. Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: The Denosumab and Teriparatide follow-up study (DATA-Follow-up). Bone. 2017;98:54-58. doi:10.1016/j.bone.2017.03.006; Cosman F, Kendler DL, Langdahl BL, Leder BZ, Lewiecki EM, Miyauchi A, et al. Romosozumab and antiresorptive treatment: The importance of treatment sequence. Osteoporos Int. 2022;33(6):1243-1256. doi:10.1007/s00198-021-06174-0; Solling AS, Harslof T, Langdahl B. Treatment with zoledronate subsequent to denosumab in osteoporosis: A 2-year randomized study. J Bone Miner Res. 2021;36:1245-1254. doi:10.1002/jbmr.4305.; Napoli N, Langdahl BL, Ljunggren Ö, Lespessailles E, Kapetanos G, Kocjan T, et al. Effects of teriparatide in patients with osteoporosis in clinical practice: 42-month results during and after discontinuation of treatment from the European Extended Forsteo® Observational Study (ExFOS). Calcif Tissue Int. 2018;103(4):359-371. doi:10.1007/s00223-018-0437-x; Amiche MA, Albaum JM, Tadrous M, Pechlivanoglou P, Lévesque LE, Adachi JD, et al. Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: A network meta-analysis. Osteoporos Int. 2016;27(6):1989-1998. doi:10.1007/s00198-015-3476-4; Kanis JA, McCloskey EV, Johansson H, Oden A, Strom O, Borgstrom F. Development and use of FRAX® in osteoporosis. Osteoporos Int. 2010;21(Suppl 2):407-413. doi:10.1007/s00198-010-1253-y; de Nijs RN, Jacobs JW, Algra A, Lems WF, Bijlsma JW. Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: A review with meta-analysis of randomized controlled trials including organ transplantation studies. Osteoporos Int. 2004;15(8):589-602. doi:10.1007/s00198-004-1614-5; Белая ЖЕ, Белова КЮ, Бирюкова ЕВ, Дедов ИИ, Дзеранова ЛК, Драпкина ОМ, и др. Федеральные клинические рекомендации по диагностике, лечению и профилактике остеопороза. Остеопороз и остеопатии. 2021;24(2):4-47. doi:10.14341/osteo12930; Лесняк ОМ (ред.). Остеопороз; 2-е издание, переработанное и дополненное. М.:ГЭОТАР-Медиа;2023.; https://rsp.mediar-press.net/rsp/article/view/3543Test

الإتاحة: https://doi.org/10.47360/1995-4484-2024-145-153Test
https://doi.org/10.1016/j.berh.2007.06.002Test
https://doi.org/10.14341/osteo201439-14Test
https://doi.org/10.1093/rheumatology/39.12.1383Test
https://doi.org/10.1002/art.22294Test
https://doi.org/10.1007/s00198-010-1524-7Test
https://doi.org/10.1002/acr.25240Test
https://doi.org/10.1016/j.jclinepi.2013.02.003Test
https://doi.org/10.1136/bmj.39489.470347.ADTest
https://doi.org/10.1210/jc.2010-2704Test

المؤلفون: M. V. Kozyreva, O. A. Nikitinskaya, N. V. Toroptsova

المصدر: Научно-практическая ревматология, Vol 60, Iss 6, Pp 587-593 (2022)

مصطلحات موضوعية: trabecular bone score, fracture risk assessment, rheumatic disease, rheumatoid arthritis, systemic sclerosis, glucocorticoids, Diseases of the musculoskeletal system, RC925-935

وصف الملف: electronic resource

العلاقة: https://rsp.mediar-press.net/rsp/article/view/3248Test; https://doaj.org/toc/1995-4484Test; https://doaj.org/toc/1995-4492Test

الوصول الحر: https://doaj.org/article/ba2d597203ac43e896833ecc8cbbcdadTest

المؤلفون: Elena Yu. Polyakova, Irina V. Kryukova, Ksenia A. Krasulina

المصدر: Alʹmanah Kliničeskoj Mediciny, Vol 50, Iss 3, Pp 158-169 (2022)

مصطلحات موضوعية: osteoporosis, fracture risk, frax, x-ray densitometry, osteoporosis center, Medicine

وصف الملف: electronic resource

العلاقة: https://almclinmed.ru/jour/article/viewFile/1707/1475Test; https://doaj.org/toc/2072-0505Test; https://doaj.org/toc/2587-9294Test

الوصول الحر: https://doaj.org/article/65ee3cc0d0d141a291a15b27858f05ceTest

المؤلفون: O. V. Yakushevskaya, S. V. Yureneva, V. I. Komedina

المصدر: Медицинский совет, Vol 0, Iss 6, Pp 116-121 (2022)

مصطلحات موضوعية: low-trauma fractures, fracture risk, estrogens, hormone replacement therapy, osteosarcopenia, Medicine

وصف الملف: electronic resource

العلاقة: https://www.med-sovet.pro/jour/article/view/6820Test; https://doaj.org/toc/2079-701XTest; https://doaj.org/toc/2658-5790Test

الوصول الحر: https://doaj.org/article/32427a7f33fd42df8b62c2cb3e5e8386Test

المؤلفون: M. V. Kozyreva, O. V. Dobrovolskaya, N. V. Demin, O. A. Nikitinskaya, N. V. Toroptsova, М. В. Козырева, О. В. Добровольская, Н. В. Демин, О. А. Никитинская, Н. В. Торопцова

المساهمون: Исследование выполнено в рамках научно-исследовательской работы № 1021051403074-2.

المصدر: Rheumatology Science and Practice; Vol 61, No 5 (2023); 602-607 ; Научно-практическая ревматология; Vol 61, No 5 (2023); 602-607 ; 1995-4492 ; 1995-4484

مصطلحات موضوعية: ревматоидный артрит, bone mineral density, bone microarchitecture, trabecular bone score, fracture risk, rheumatic diseases, rheumatoid arthritis, минеральная плотность кости, микроархитектоника кости, трабекулярный костный индекс, риск переломов, ревматические заболевания

وصف الملف: application/pdf

العلاقة: https://rsp.mediar-press.net/rsp/article/view/3444/2323Test; Белая ЖЕ, Белова КЮ, Бирюкова ЕВ, Дедов ИИ, Дзеранова ЛК, Драпкина ОМ, и др. Федеральные клинические рекомендации по диагностике, лечению и профилактике остеопороза. Остеопороз и остеопатии. 2021;24(2):4-47. doi:10.14341/osteo12930; Ørstavik RE, Haugeberg G, Mowinckel P, Høiseth A, Uhlig T, Falch JA, et al. Vertebral deformities in rheumatoid arthritis: a comparison with population-based controls. Arch Intern Med. 2004;164(4):420-425. doi:10.1001/archinte.164.4.420; Лесняк ОМ (ред.). Остеопороз: руководство для врачей. М.:ГЭОТАР-Медиа;2016.; Muschitz C, Kocijan R, Haschka J, Pahr D, Kaider A, Pietschmann P, et al. TBS reflects trabecular microarchitecture in premenopausal women and men with idiopathic osteoporosis and low-traumatic fractures. Bone. 2015;79:259-266. doi:10.1016/j.bone.2015.06.007; Roux JP, Wegrzyn J, Boutroy S, Bouxsein ML, Hans D, Chapurlat R. The predictive value of trabecular bone score (TBS) on whole lumbar vertebrae mechanics: An ex vivo study. Osteoporos Int. 2013;24(9):2455-2460. doi:10.1007/s00198-013-2316-7; Winzenrieth R, Dufour R, Pothuaud L, Hans D. A retrospective case-control study assessing the role of trabecular bone score in postmenopausal Caucasian women with osteopenia: Analyzing the odds of vertebral fracture. Calcif Tissue Int. 2010;86(2):104-109. doi:10.1007/s00223-009-9322-y; McCloskey EV, Odén A, Harvey NC, Leslie WD, Hans D, Johansson H, et al. A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res. 2016;31(5):940-948. doi:10.1002/jbmr.2734; Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, et al. Trabecular bone score: A noninvasive analytical method based upon the DXA image. J Bone Miner Res. 2014;29(3):518-530. doi:10.1002/jbmr.2176; Roux C. Osteoporosis in inflammatory joint diseases. Osteoporos Int. 2011;22(2):421-433. doi:10.1007/s00198-010-1319-x; Richards C, Leslie WD. Trabecular bone score in rheumatic disease. Curr Rheumatol Rep. 2022;24(4):81-87. doi:10.1007/s11926-022-01062-w; Bréban S, Briot K, Kolta S, Paternotte S, Ghazi M, Fechtenbaum J, Roux C. Identification of rheumatoid arthritis patients with vertebral fractures using bone mineral density and trabecular bone score. J Clin Densitom. 2012;15(3):260-266. doi:10.1016/j.jocd.2012.01.007; Choi YJ, Chung YS, Suh CH, Jung JY, Kim HA. Trabecular bone score as a supplementary tool for the discrimination of osteoporotic fractures in postmenopausal women with rheumatoid arthritis. Medicine (Baltimore). 2017;96(45):e8661. doi:10.1097/MD.0000000000008661; Kim D, Cho SK, Kim JY, Choi YY, Sung YK. Association between trabecular bone score and risk factors for fractures in Korean female patients with rheumatoid arthritis. Mod Rheumatol. 2016;26(4):540-545. doi:10.3109/14397595.2015.1101212; Buehring B, Thomas J, Wittkämper T, Baraliakos X, Braun J. Evaluation of the trabecular bone score (TBS) in routine clinical care of patients with inflammatory rheumatic and non-inflammatory diseases: Correlation with conventional bone mineral density measurement and prevalence of vertebral fractures. Z Rheumatol. 2020;79(10):1067-1074. doi:10.1007/s00393-020-00764-9; https://rsp.mediar-press.net/rsp/article/view/3444Test

الإتاحة: https://doi.org/10.47360/1995-4484-2023-602-607Test
https://doi.org/10.14341/osteo12930Test
https://doi.org/10.1001/archinte.164.4.420Test
https://doi.org/10.1016/j.bone.2015.06.007Test
https://doi.org/10.1007/s00198-013-2316-7Test
https://doi.org/10.1007/s00223-009-9322-yTest
https://doi.org/10.1002/jbmr.2734Test
https://doi.org/10.1002/jbmr.2176Test
https://doi.org/10.1007/s00198-010-1319-xTest
https://doi.org/10.1007/s11926-022-01062-wTest

المؤلفون: L. A. Marchenkova, Л. А. Марченкова

المصدر: Meditsinskiy sovet = Medical Council; № 9 (2023); 104-113 ; Медицинский Совет; № 9 (2023); 104-113 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: риск переломов, quality of life, pain syndrome, adherence to treatment, fracture risk, качество жизни, болевой синдром, приверженность лечению

وصف الملف: application/pdf

العلاقة: https://www.med-sovet.pro/jour/article/view/7612/6761Test; Белая Ж.Е., Рожинская Л.Я., Гребенникова Т.А., Kanis J.А., Пигарова Е.А., Родионова С.С. и др. Краткое изложение проекта федеральных клинических рекомендаций по остеопорозу. Остеопороз и остеопатии. 2020;23(2):4–21. https://doi.org/10.14341/osteo12710Test.; Belaya Z.E., Rozhinskaya L.Y., Grebennikova T.A., Kanis J.A., Pigarova E.A., Rodionova S.S. et al. Summary of the draft federal clinical guidelines for osteoporosis. Osteoporosis and Bone Diseases. 2020;23(2):4–21. (In Russ.) https://doi.org/10.14341/osteo12710Test.; Kanis J.A., Cooper C., Rizzoli R., Reginster J.Y. Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30(1):3–44. https://doi.org/10.1007/s00198-018-4704-5Test.; Hernlund E., Svedbom A., Ivergård M., Compston J., Cooper C., Stenmark J. et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8(1):136. https://doi.org/10.1007/s11657-013-0136-1Test.; Михайлов Е.Е., Беневоленская Л.И., Мылов Н.М. Распространенность переломов позвоночника в популяционной выборке лиц 50 лет и старше. Вестник травматологии и ортопедии. 1997;(3):20–27. https://doi.org/10.17816/vto108314Test.; Mikhailov E.E., Benevolenskaya L.I., Mylov N.M. Spine fractures in population selection of persons of 50 years and older. N.N. Priorov Journal of Traumatology and Orthopedics. 1997;(3):20–27. (In Russ.) https://doi.org/10.17816/vto108314Test.; Longo U.G., Loppini M., Denaro L., Maffulli N., Denaro V. Osteoporotic vertebral fractures: current concepts of conservative care. Br Med Bull. 2012;102:171–189. https://doi.org/10.1093/bmb/ldr048Test.; Prather H., Hunt D., Watson J.O., Gilula L.A. Conservative care for patients with osteoporotic vertebral compression fractures. Phys Med Rehabil Clin N Am. 2007;18(3):577–591. https://doi.org/10.1016/j.pmr.2007.05.008Test.; Bautmans I., Van Arken J., Van Mackelenberg M., Mets T. Rehabilitation using manual mobilization for thoracic kyphosis in elderly postmenopausal patients with osteoporosis. J Rehabil Med. 2010;42(2):129–135. https://doi.org/10.2340/16501977-0486Test.; Giangregorio L.M., Macintyre N.J., Thabane L., Skidmore C.J., Papaioannou A. Exercise for improving outcomes after osteoporotic vertebral fracture. Cochrane Database Syst Rev. 2013;1:CD008618. https://doi.org/10.1002/14651858.CD008618.pub2Test.; Conley R.B., Adib G., Adler R.A., Åkesson K.E., Alexander I.M., Amenta K.C. et al. Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition. J Bone Miner Res. 2020;35(1):36–52. https://doi.org/10.1002/jbmr.3877Test.; Shibasaki K., Asahi T., Kuribayashi M., Tajima Y., Marubayashi M., Iwama R. et al. Potential prescribing omissions of anti-osteoporosis drugs is associated with rehabilitation outcomes after fragility fracture: Retrospective cohort study. Geriatr Gerontol Int. 2021;21(5):386–391. https://doi.org/10.1111/ggi.14145Test.; Марченкова Л.А., Макарова Е.В., Васильева В.А., Еремушкин М.А. Роль длительного приема добавок кальция и витаминов D3 и B6 в поддержании эффекта медицинской реабилитации у пациентов с остеопорозом и высоким риском переломов. Остеопороз и остеопатии. 2020;23(1):110–111. Режим доступа: https://www.osteo-endojournals.ru/jour/article/view/12779Test.; Marchenkova L.A., Makarova E.V., Vasilyeva V.A., Eremushkin M.A. The role of long-term intake of calcium supplements, vitamins D3 and B6 in maintaining the effect of medical rehabilitation in patients with osteoporosis and high risk of fractures. Osteoporosis and Bone Diseases. 2020;23(1):110–111. (In Russ.) Available at: https://www.osteo-endojournals.ru/jour/article/view/12779Test.; Марченкова Л.А., Макарова Е.В., Васильева В.А. Влияние HDBA органик комплекса с витамином D и кальцием на качество жизни у лиц с высоким риском переломов, проходящих медицинскую реабилитацию. Вестник восстановительной медицины. 2020;97(3):153–159. https://doi.org/10.38025/2078-1962-2020-97-3-153-159Test.; Marchenkova L.A., Makarova E.V., Vasileva V.A. The influence of HDBA organic complex with vitamin D and calcium on quality of life in individuals at high risk of fractures undergoing medical rehabilitation. Vestnik Vosstanovitelʹnoj Mediciny. 2020;97(3):153–159. (In Russ.) https://doi.org/10.38025/2078-1962-2020-97-3-153-159Test.; Макарова Е.В., Марченкова Л.А., Еремушкин М.А., Стяжкина Е.М., Разваляева Д.В. Эффективность нового комплексного метода реабилитации с использованием механо- и кинезиотерапии в коррекции нарушении баланса у пациентов с компрессионными переломами позвонков на фоне остеопороза. Вестник восстановительной медицины. 2020;97(3):160–166. https://doi.org/10.38025/2078-1962-2020-97-3-160-166Test.; Makarova E.V., Marchenkova L.A., Eremushkin M.A., Styazhkina E.M., Razvalyaeva D.V. Efficiency of a new complex rehabilitation method using mechano- and kinesiotherapy for balance disorders correction in patients with osteoporotic compression vertebral fractures. Vestnik Vosstanovitelʹnoj Mediciny. 2020;97(3):160–166. (In Russ.) https://doi.org/10.38025/2078-1962-2020-97-3-160-166Test.; Lips P., Cooper C., Agnusdei D., Caulin F., Egger P., Johnell O. et al. Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int. 1999;10(2):150–160. https://doi.org/10.1007/s001980050210Test.; Буйлова Т.В. Современные подходы к реабилитации пациентов с остеопорозом. международная классификация функционирования и реабилитационный диагноз. Остеопороз и остеопатии. 2020;23(1):58–59. Режим доступа: https://www.osteo-endojournals.Ru/jour/article/view/12745Test.; Builova T.V. Modern approaches to rehabilitation of patients with osteoporosis. international classification of functioning and rehabilitation diagnosis. Osteoporosis and Bone Diseases. 2020;23(1):58–59. (In Russ.) Available at: https://www.osteo-endojournals.ru/jour/article/view/12745Test.; Егудина Е.Д., Калашникова О.С. Физическая реабилитация пациентов с остеопорозом. Вопросы курортологии, физиотерапии и лечебной физической культуры. 2020;97(2):78–85. https://doi.org/10.17116/kurort20209702178Test.; Egudina E.D., Kalashnikova O.S. Physical rehabilitation of patients with osteoporosis. Voprosy Kurortologii, Fizioterapii, i Lechebnoi Fizicheskoi Kultury. 2020;97(2):78–85. (In Russ.) https://doi.org/10.17116/kurort20209702178Test.; Erhan B., Ataker Y. Rehabilitation of Patients With Osteoporotic Fractures. J Clin Densitom. 2020;23(4):534–538. https://doi.org/10.1016/j.jocd.2020.06.006Test.; Oral A., Küçükdeveci A.A., Varela E., Ilieva E.M., Valero R., Berteanu M., Christodoulou N. Osteoporosis. The role of physical and rehabilitation medicine physicians. The European perspective based on the best evidence. A paper by the UEMS-PRM Section Professional Practice Committee. Eur J Phys Rehabil Med. 2013;49(4):565–577. Available at: https://pubmed.ncbi.nlm.nih.gov/24084415Test/.; Anderson P.A., Dimar J.R., Lane J.M., Lehman RA Jr. Rationale for Bone Health Optimization in Patients Undergoing Orthopaedic Surgery. Instr Course Lect. 2021;70:355–366. Available at: https://pubmed.ncbi.nlm.nih.gov/33438921Test/.; Di Monaco M., Castiglioni C., Bardesono F., Milano E., Massazza G. Sarcopenia, osteoporosis and the burden of prevalent vertebral fractures: a cross-sectional study of 350 women with hip fracture. Eur J Phys Rehabil Med. 2020;56(2):184–190. https://doi.org/10.23736/S1973-9087.20.05991-2Test.; St Jeor J.D., Jackson T.J., Xiong A.E., Kadri A., Freedman B.A., Sebastian A.S. et al. Osteoporosis in spine surgery patients: what is the best way to diagnose osteoporosis in this population? Neurosurg Focus. 2020;49(2):E4. https://doi.org/10.3171/2020.5.FOCUS20277Test.; Марченкова Л.А., Макарова Е.В., Герасименко М.Ю. Распространенность остеопороза, ассоциирующихся с ним переломов и уровня информированности по проблеме среди пациентов, проходящих медицинскую реабили. Лечащий врач. 2020;(2):54–57. https://doi.org/10.26295/OS.2020.16.46.010Test.; Marchenkova L.A., Makarova E.V., Gerasimenko M.Yu. Prevalence of osteoporosis, associated fractures, and level of knowledge about this problem among the patients undergoing medical rehabilitation. Lechaschi Vrach. 2020;(2):54–57. (In Russ.) https://doi.org/10.26295/OS.2020.16.46.010Test.; Black D.M., Delmas P.D., Eastell R., Reid I.R., Boonen S., Cauley J.A. et al. Onceyearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007;356(18):1809–1822. https://doi.org/10.1056/NEJMoa067312Test.; Black D.M., Reid I.R., Boonen S., Bucci-Rechtweg C., Cauley J.A., Cosman F. et al. The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res. 2012;27(2):243–254. https://doi.org/10.1002/jbmr.1494Test.; Black D.M., Reid I.R., Cauley J.A., Cosman F., Leung P.C., Lakatos P. et al. The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res. 2015;30(5):934–944. https://doi.org/10.1002/jbmr.2442Test.; Lyles K.W., Colón-Emeric C.S., Magaziner J.S., Adachi J.D., Pieper C.F., Mautalen C. et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007;357(18):1799–1809. https://doi.org/10.1056/NEJMoa074941Test.; Марченкова Л.А., Древаль А.В., Прохорова Е.А., Лосева В.А. Приверженность больных постменопаузальным остеопорозом комбинированной терапии алендронатом натрия и колекальциферолом и ее влияние на эффективность лечения. Проблемы эндокринологии. 2014;60(4):22–29. https://doi.org/10.14341/probl201460422-29Test.; Marchenkova L.A., Dreval A.V., Prokhorova E.A., Loseva V.A. The adherence of postmenopausal osteoporosis patients to therapy with combination medication contains alendronic acid and colecalciferol and its impact on the effectiveness of treatment. Problems of Endocrinology. 2014;60(4):22–29. (In Russ.) https://doi.org/10.14341/probl201460422-29Test.; Landfeldt E., Ström O., Robbins S., Borgström F. Adherence to treatment of primary osteoporosis and its association to fractures--the Swedish Adherence Register Analysis (SARA). Osteoporos Int. 2012;23(2):433–443. https://doi.org/10.1007/s00198-011-1549-6Test.; Reid D.M., Devogelaer J.P., Saag K., Roux C., Lau C.S., Reginster J.Y. et al. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet. 2009;373(9671):1253–1263. https://doi.org/10.1016/S0140-6736Test(09)60250-6.; Dusdal K., Grundmanis J., Luttin K., Ritchie P., Rompre C., Sidhu R., Harris S.R. Effects of therapeutic exercise for persons with osteoporotic vertebral fractures: a systematic review. Osteoporos Int. 2011;22(3):755–769. https://doi.org/10.1007/s00198-010-1497-6Test.; Garg B., Dixit V., Batra S., Malhotra R., Sharan A. Non-surgical management of acute osteoporotic vertebral compression fracture: A review. J Clin Orthop Trauma. 2017;8(2):131–138. https://doi.org/10.1016/j.jcot.2017.02.001Test.; Giangregorio L., Papaioannou A., Cranney A., Zytaruk N., Adachi J.D. Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum. 2006;35(5):293–305. https://doi.org/10.1016/j.semarthrit.2005.11.001Test.; Hadji P., Ziller V., Gamerdinger D., Spieler W., Articus K., Baier M., Moericke R., Kann P.H. Quality of life and health status with zoledronic acid and generic alendronate: a secondary analysis of the Rapid Onset and Sustained Efficacy (ROSE) study in postmenopausal women with low bone mass. Osteoporos Int. 2012;23(7):2043–2051. https://doi.org/10.1007/s00198-011-1834-4Test.; Lambrinoudaki I., Vlachou S., Galapi F., Papadimitriou D., Papadias K. Onceyearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women. Clin Interv Aging. 2008;3(3):445–451. https://doi.org/10.2147/cia.s2046Test.; Hamdy R.C. Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass. Drug Des Devel Ther. 2010;(4):321–335. https://doi.org/10.2147/DDDT.S6287Test.; https://www.med-sovet.pro/jour/article/view/7612Test

الإتاحة: https://doi.org/10.21518/ms2023-154Test
https://doi.org/10.14341/osteo12710Test
https://doi.org/10.1007/s00198-018-4704-5Test
https://doi.org/10.1007/s11657-013-0136-1Test
https://doi.org/10.17816/vto108314Test
https://doi.org/10.1093/bmb/ldr048Test
https://doi.org/10.1016/j.pmr.2007.05.008Test
https://doi.org/10.2340/16501977-0486Test
https://doi.org/10.1002/14651858.CD008618.pub2Test
https://doi.org/10.1002/jbmr.3877Test

المؤلفون: Alexey V. Petraikin, Kristina A. Sergunova, Lyudmila A. Nisovstova, Alexander V. Soloviev, Fedor A. Petryaykin, Ekaterina S. Akhmad, Dmitry S. Semenov, Lia R. Abuladze, Leila R. Iassin, Anastasia N. Kiseleva, Anton V. Vladzymyrskyy, Sergey P. Morozov

المصدر: Гений oртопедии, Vol 27, Iss 6, Pp 800-807 (2021)

مصطلحات موضوعية: osteoporosis, treatment, risk factors, fracture risk assessment tool, quantitative computed tomography, bone mineral density, t-score, osteodensitometry, Orthopedic surgery, RD701-811

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1028-4427Test; https://doaj.org/toc/2542-131XTest

الوصول الحر: https://doaj.org/article/9d289d15f92b4279a21ff91ca65829d4Test

المؤلفون: Polyakova E.Y., Kryukova I.V., Krasulina K.A.

المساهمون: 1

المصدر: Almanac of Clinical Medicine; Vol 50, No 3 (2022); 158-169 ; Альманах клинической медицины; Vol 50, No 3 (2022); 158-169 ; 2587-9294 ; 2072-0505

مصطلحات موضوعية: osteoporosis, fracture risk, FRAX, X-ray densitometry, osteoporosis center, остеопороз, риск переломов, рентгеновская денситометрия, центр остеопороза

وصف الملف: application/pdf

العلاقة: https://almclinmed.ru/jour/article/view/1707/1475Test; https://almclinmed.ru/jour/article/view/1707/1481Test; https://almclinmed.ru/jour/article/view/1707/1492Test; https://almclinmed.ru/jour/article/downloadSuppFile/1707/2893Test; https://almclinmed.ru/jour/article/downloadSuppFile/1707/2967Test; https://almclinmed.ru/jour/article/downloadSuppFile/1707/2968Test; https://almclinmed.ru/jour/article/downloadSuppFile/1707/2969Test; https://almclinmed.ru/jour/article/downloadSuppFile/1707/2970Test; https://almclinmed.ru/jour/article/downloadSuppFile/1707/3065Test; https://almclinmed.ru/jour/article/downloadSuppFile/1707/3066Test; https://almclinmed.ru/jour/article/downloadSuppFile/1707/3067Test; https://almclinmed.ru/jour/article/downloadSuppFile/1707/3068Test; https://almclinmed.ru/jour/article/downloadSuppFile/1707/3069Test; https://almclinmed.ru/jour/article/downloadSuppFile/1707/3070Test; https://almclinmed.ru/jour/article/view/1707Test

الإتاحة: https://doi.org/10.18786/2072-0505-2022-50-024Test
https://almclinmed.ru/jour/article/view/1707Test

المؤلفون: O. V. Dobrovolskaya, A. O. Efremova, N. V. Demin, N. V. Toroptsova

المصدر: Медицинский совет, Vol 0, Iss 8, Pp 120-127 (2020)

مصطلحات موضوعية: bone mineral density, rheumatoid arthritis, systemic scleroderma, osteoarthritis, frax®, fracture risk, need for antiosteoporotic therapy, Medicine

وصف الملف: electronic resource

العلاقة: https://www.med-sovet.pro/jour/article/view/5689Test; https://doaj.org/toc/2079-701XTest; https://doaj.org/toc/2658-5790Test

الوصول الحر: https://doaj.org/article/6c684262e38e4ef08c21f79f89c633f9Test

المؤلفون: L. A. Marchenkova, E. V. Makarova

المصدر: Медицинский совет, Vol 0, Iss 7, Pp 122-128 (2020)

مصطلحات موضوعية: osteoporosis, alendronate, fracture risk, personalized medicine, compliance, adverse drug effects, Medicine

وصف الملف: electronic resource

العلاقة: https://www.med-sovet.pro/jour/article/view/5663Test; https://doaj.org/toc/2079-701XTest; https://doaj.org/toc/2658-5790Test

الوصول الحر: https://doaj.org/article/d25e1b1f7a9c4204b60c661cc3b1281dTest